NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Subjects endoscopically diagnosed erosive esophagitis
Date of first enrollment	14/03/2008
Target sample size	850
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : TAK-390MR INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Healing rate of erosive esophagitis at 8 weeks
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	1. Subjects endoscopically diagnosed with Los Angeles grade A-D erosive esophagitis 2. Male or female subject at least 20 years of age at time of obtaining consent
Exclude criteria